The worlds #1 website for end of day & historical stock data
wide range of exchanges, data formats, tools and services
API
NEW
HISTORICAL DATA
SYMBOL LISTS
MEMBERSHIP
REGISTER
LOG IN
Toggle navigation
HOME
Home Page
Download
Symbol Lists
Quote & Chart
Symbol Changes
Splits
Dividends
PRODUCTS & SERVICES
Membership Levels
Conversion Utility
Data Client
Historical Data
Fundamental Data
Commercial Feeds
Web Service
HOW TO
Advanced Get
AIQ
AMIBroker
EzyChart
MetaStock
OmniTrader
SuperCharts
TradeStation
SUPPORT
FAQ
Data Formats
Data Quality
Forgotten Password
Submit a Support Request
ABOUT
About Us
Contact Us
Terms & Conditions
Privacy Policy
Useful Links
MY ACCOUNT
Downloads
Account Details
API
Buy Historical Data
Billing History
Data Format
Daily Emails
Watchlists
NASDAQ, DCTH:
29 Aug 2025
LAST:
11.02
CHANGE:
0.14
OPEN:
10.91
HIGH:
11.03
ASK:
0.11
VOLUME:
332.6K
CHG(%):
1.29
PREV:
10.88
LOW:
10.65
BID:
3.88
CHART
Period:
End of Day
1 Minute
5 Minute
10 Minute
15 Minute
30 Minute
Hourly
Weekly
Monthly
Yearly
RECENT END OF DAY PRICES
Date
Open
High
Low
Close
Volume
29 Aug 25
10.91
11.03
10.65
11.02
332.6K
28 Aug 25
10.93
11.02
10.77
10.88
326.3K
27 Aug 25
11.09
11.35
10.93
10.94
380.7K
26 Aug 25
10.89
11.21
10.89
11.12
360.3K
25 Aug 25
11.18
11.31
10.86
10.89
694.7K
22 Aug 25
10.43
11.25
10.43
11.12
772K
21 Aug 25
10.37
10.61
10.25
10.41
413.2K
20 Aug 25
10.56
10.60
10.06
10.33
455.6K
19 Aug 25
10.56
10.60
10.21
10.56
841.2K
18 Aug 25
10.30
10.81
10.30
10.65
574.7K
COMPANY PROFILE
Name:
About:
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. The company was founded in 1987 and is headquartered in New York, New York.
Sector:
Healthcare
Address:
566 Queensbury Avenue, New York, NY, United States, 12804
Website:
https://www.delcath.com
CUSIP:
24661P807
CIK:
0000872912
ISIN:
US24661P8077
FIGI:
BBG000BY2VF5
LEI:
549300NVPLITUM6URT02
SYMBOL HISTORY
Purchase End of Day History
for this symbol from Oct 23, 2001
Purchase Intraday History
for this symbol from Oct 23, 2001
Add to Watchlist
ADD TO WATCHLIST
Please select which Watchlist you would like to add this symbol to:
Watchlist:
DOWNLOAD DATA
Download stock quote history quickly and easily in a variety of formats to suit your needs.
Exchange:
American Stock Exchange
Australian Securities Exchange
Chicago Futures Exchange
Cryptocurrencies
EUREX Futures Exchange
Euronext - Amsterdam
Euronext - Brussels
Euronext - Lisbon
Euronext - Oslo
Euronext - Paris
Foreign Exchange
Frankfurt Exchange
Global Indices
LIFFE Futures and Options
London Stock Exchange
Madrid Stock Exchange
Minneapolis Grain Exchange
Mutual Funds
NASDAQ Stock Exchange
National Stock Exchange of India
New York Board of Trade
New York Stock Exchange
OTC Bulletin Board
Shanghai Stock Exchange
Shenzhen Stock Exchange
Singapore Stock Exchange
Toronto Stock Exchange
Toronto Venture Exchange
Winnipeg Commodity Exchange
Format:
3F VIP Trading
Advanced Get ASCII
AGet ASCII
AIQ Trading Expert Pro
Ami Broker
Ami Broker with Names
Andromeda
ASCII (Intraday)
EzyCharts
FCharts
FCharts (Intraday)
MetaStock ASCII (7 column)
MetaStock ASCII (8 column)
Metastock ASCII (Intraday)
MetaStock ASCII with Names
Personal Stock Streamer
Quicken
SpiffyCharts
Spreadsheet (eg: Excel)
Standard CSV
Stock Screener Pro
SuperCharts ASCII
Wal Data Platinum
Windows on Wallstreet
Period:
End of Day
1 Minute Bars
5 Minute Bars
10 Minute Bars
15 Minute Bars
30 Minute Bars
60 Minute Bars
Zip file
Symbol:
Start Date:
End Date:
Download
FUNDAMENTALS
P/E Ratio:
117.33
PtB:
3.52
PtS:
5.26
EBITDA:
5.18M
Shares:
34.98M
Market Cap:
385.49M
TECHNICAL INDICATORS
MA5:
10.97
MA10:
10.79
MA20:
10.69
MA50:
11.54
MA100:
12.94
MA200:
12.97
STO9:
67.65
STO14:
67.65
RSI14:
57.10
WPR14:
-12.66
MTM14:
0.14
ROC14:
0.01
ATR:
0.46
Week High:
11.35
Week Low:
10.43
Month High:
13.44
Month Low:
9.87
Year High:
18.23
Year Low:
8.08
Volatility:
12.68
RECENT SPLITS
Date
Ratio
24 Dec 2019
1-700
22 Oct 2019
1-100
03 May 2018
1-500
02 May 2018
1-500
06 Nov 2017
1-350
21 Jul 2016
1-16
09 Apr 2014
1-16